Magnesium Glycinate Chelate
Goals
$33.49 $0.55 per serving
Product analysis
Magnesium Glycinate Chelate targets magnesium intake in a single-mineral formula. Its buffered mixture includes oxide in undisclosed proportions, limiting the appeal of the glycinate description.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality36
Glycinate is combined with less readily absorbed magnesium oxide. The unknown shares make it hard to judge how much of the favorable form is supplied.
Ingredient Transparency100
The magnesium amount and buffered source are identified. Those details help track intake, although they do not reveal the proportions within the mixture.
Value For Money30
The buffered mixture offers limited value for its combination of forms. Unclear proportions make it harder to justify the cost from the glycinate component alone.
Customer Satisfaction77
Ratings suggest very high satisfaction across several hundred customer opinions. They do not establish absorption, tolerance or health outcomes.
Product Focus66
Magnesium is the sole active mineral, making its nutritional purpose clear. Its many possible uses still depend on whether extra magnesium is needed.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $0.55
- Also available
Magnesium Glycinate Chelate$64.99- Customer rating
- 4.8 · 332 ratings
Goals
Impact
High effect
Magnesium · 300 mg
Magnesium may help with stress-related symptoms when magnesium intake is low or in selected clinical settings. This product provides 300 mg of elemental magnesium per serving, with the relevant connection centered on calming. Broad, lasting relief from everyday stress remains uncertain.
How this product is rated for Stress Relief
Ingredient fit85
Magnesium provides a focused ingredient connection to stress support.
Goal fit
Magnesium is relevant to this goal, although it is also used across other goals.
Dose adequacy
The declared serving receives substantial, partial amount recognition in the saved findings.
Pathways45
The main connection is calming, with a smaller contribution to stress-hormone regulation.
Depth
Calming is the strongest covered route, but coverage remains incomplete.
Breadth
Only calming reaches substantial coverage; stress-hormone regulation remains a smaller contribution.
Evidence76
Magnesium's stress findings are conditional on low intake or selected clinical settings, with uncertain everyday applicability.
Evidence strength
Magnesium provides the strongest evidence available in this formula, with conditional stress findings.
Studied preparation
The saved findings recognize the declared preparation; this does not establish equal absorption across magnesium salts.
Formulation logic100
Magnesium can contribute without missing partners, and none of the checked conflicts was triggered.
Partner coverage
No required partner is missing from the credited ingredients.
Conflicts
None of the checked stimulant or ingredient-combination conflicts was triggered.
Effective doses
Magnesium reaches the amount threshold used for a meaningful contribution.
Impact
Highest effect
Magnesium · 300 mg
Magnesium contributes to normal energy and mineral metabolism, with usefulness mainly when dietary intake falls short. Amounts above nutritional adequacy do not establish additional general-health benefit.
How this product is rated for Everyday Health
Ingredient fit92
Magnesium connects this product to routine nutrient provision. Its practical value depends on filling dietary gaps.
Goal fit
The included nutrients stay focused on routine nutritional support, although the product is linked to several health goals.
Dose adequacy
The relevant amounts reach the supplied comparison endpoints; higher amounts do not demonstrate additional benefit above adequate intake.
Pathways80
Normal energy metabolism is the strongest represented nutritional role. Several nutritional roles are represented.
Depth
Normal energy metabolism is the strongest represented nutritional role.
Breadth
The represented roles include energy metabolism cofactors, bone and mineral metabolism, with breadth determined by the supplied amounts.
Evidence86
Magnesium is the main contributor to the saved evidence finding. The supplied evidence supports nutritional usefulness when intake is low, without establishing extra benefit in adequately nourished adults.
Evidence strength
Magnesium leads the saved evidence finding; its relevance is nutritional support when intake is low, without established benefit above adequacy.
Studied preparation
The included nutrient declarations satisfy the supplied preparation checks, without evidence that a particular form or delivery method provides greater general-health benefit.
Formulation logic100
The supplied checks identify no missing required partner or configured conflict. Included nutrient amounts meet the comparison threshold.
Partner coverage
No required nutrient partner is missing under the supplied checks; co-presence does not establish added benefit from the combination.
Conflicts
No configured ingredient conflict was identified in the supplied checks.
Effective doses
The included contributions meet the supplied amount threshold, which describes nutrient availability rather than a proven health-outcome dose.
Impact
High effect
Magnesium · 300 mg
Magnesium can help address fatigue and weakness caused by low magnesium intake or deficiency. This serving makes a nutritional contribution, but higher amounts do not establish more energy when intake is adequate. The supplied information does not show that malate, glycinate, citrate or a blend of forms independently improves routine fatigue or alertness.
How this product is rated for Energy
Ingredient fit85
Magnesium provides a relevant contribution, primarily for deficiency-related tiredness. The formula's amounts contribute at differing levels.
Goal fit
Magnesium provides a relevant contribution, primarily for deficiency-related tiredness.
Dose adequacy
The declared serving makes a partial saved amount contribution, without establishing a clinical treatment regimen.
Pathways0
No direct alertness, exercise or other configured energy area receives coverage; nutritional deficiency correction remains a separate role.
Depth
No configured energy area receives a direct contribution; this does not negate the nutritional role in correcting deficiency.
Breadth
No configured energy area reaches the saved coverage threshold.
Evidence88
Magnesium supplies the leading saved evidence contribution. Its relevant population and use conditions limit expectations.
Evidence strength
Magnesium supplies the leading evidence contribution, with its specific nutritional, population or exercise limitations.
Studied preparation
The retained contributors meet the saved preparation check; that does not establish superior fatigue relief for the declared forms.
Formulation logic100
The retained contributors need no missing partner under the supplied checks. No configured conflict was found.
Partner coverage
The retained contributors can contribute without an additional partner under the supplied checks; no extra combination benefit is established.
Conflicts
No configured conflict was found; the supplied checks do not evaluate every possible interaction.
Effective doses
Every retained contributor reaches the saved minimum amount condition; this does not establish an effective fatigue-treatment or exercise regimen.
Impact
High effect
Magnesium · 300 mg
Magnesium has a limited connection with testosterone markers in small exercise-related studies. Those findings do not establish a routine testosterone increase in nutrient-replete adults, and the declared form has no demonstrated hormone advantage.
How this product is rated for Testosterone Support
Ingredient fit92
Magnesium provide the relevant declared ingredients; their human hormone findings constrain what the serving amounts can mean.
Goal fit
The retained ingredients are focused on testosterone-related roles, although relevance depends on their human hormone findings.
Dose adequacy
The declared amounts reach the full amount comparison; this does not establish a proven testosterone-enhancing dose.
Pathways70
The strongest represented area is free-testosterone availability, without establishing that supplementation changes this outcome in routine use. Coverage reaches the comparison threshold for free-testosterone availability, with limited breadth across other hormone-related areas.
Depth
The strongest represented area is free-testosterone availability, without establishing that supplementation changes this outcome in routine use.
Breadth
Coverage reaches the comparison threshold for free-testosterone availability, with limited breadth across other hormone-related areas.
Evidence74
The retained evidence chiefly reflects Magnesium, with preparation matching considered separately from applicability to routine use.
Evidence strength
Magnesium supplies the strongest retained evidence contribution, subject to its population-specific limitations.
Studied preparation
The retained contributing preparations meet the matching check; this does not establish broader testosterone benefits beyond the studied populations.
Formulation logic100
The retained contributors satisfy the required-partner and minimum-amount checks, and no listed conflict was triggered.
Partner coverage
No retained contributor is missing a required partner in these checks; combining them does not establish a greater hormone effect.
Conflicts
No listed ingredient conflict was triggered by the supplied facts.
Effective doses
All retained contributors meet the minimum amount threshold, which is a comparison convention rather than a proven testosterone-enhancing dose.
Impact
High effect
Magnesium · 300 mg
Magnesium offers limited support for vascular function, with inconsistent findings on arterial stiffness and blood pressure. The declared 300 mg serving receives partial amount-based recognition, without demonstrating a larger clinical effect or personal suitability. The supplied evidence does not establish superior cardiovascular benefit from its particular form or prevention of cardiovascular events.
How this product is rated for Cardiovascular Support
Ingredient fit85
The recognized ingredients give the formula a focused cardiovascular connection, without establishing a clinical effect. The magnesium amount receives partial recognition; this does not establish larger benefit or personal suitability.
Goal fit
The recognized ingredients give the formula a focused cardiovascular connection, without establishing a clinical effect.
Dose adequacy
The magnesium amount receives partial recognition; this does not establish larger benefit or personal suitability.
Pathways48
The saved support centers on triglyceride metabolism, without establishing cardiovascular-event prevention.
Depth
The saved support centers on triglyceride metabolism, without establishing cardiovascular-event prevention.
Breadth
Only the leading area meets the saved coverage criterion, leaving support narrow across the assessed cardiovascular areas.
Evidence79
Magnesium leads the recognized evidence, with inconsistent arterial-stiffness and blood-pressure findings.
Evidence strength
Magnesium leads the recognized evidence, with inconsistent arterial-stiffness and blood-pressure findings.
Studied preparation
The saved result recognizes the preparations retained for this check; that recognition does not expand their demonstrated clinical benefits.
Formulation logic100
No required partner is missing and no configured conflict was matched. All ingredients retained for this check meet its minimum amount criterion; this does not establish effective clinical dosing.
Partner coverage
The recognized ingredients can contribute alone or have their required partner; no missing-partner limitation was found.
Conflicts
No configured conflict was matched in the supplied facts; this does not establish general safety.
Effective doses
All ingredients retained for this check meet its minimum amount criterion; this does not establish effective clinical dosing.
Impact
Highest effect
Magnesium · 300 mg
Magnesium contributes to electrolyte balance and blood-vessel tone, with marginal and inconsistent blood-pressure effects. The 300 mg per serving provides a substantial declared amount, though the saved comparison gives it less amount recognition than higher servings. Buffered glycinate does not establish superior heart benefits, and the support remains concentrated on blood-vessel tone.
How this product is rated for Heart Health
Ingredient fit85
Magnesium is recognized in the saved findings. Serving amounts limit the amount comparison.
Goal fit
Magnesium provides the main connection to the goal; the product’s links to other goals also reduce its focus here.
Dose adequacy
The recognized serving amounts receive partial recognition; smaller or unresolved amounts limit the saved comparison.
Pathways51
The recognized contribution centers on electrolyte balance and blood-vessel tone. Other evaluated routes have little or no comparable coverage.
Depth
The strongest recognized connection is to electrolyte balance and blood-vessel tone.
Breadth
Coverage is concentrated on electrolyte balance and blood-vessel tone, rather than spread across the other evaluated routes.
Evidence89
The saved result recognizes the included ingredients and preparations, while their specific benefits remain limited by inconsistent blood-pressure findings or conditional nutrient and homocysteine roles.
Evidence strength
Magnesium or the included B vitamins lead the saved evidence finding; their recognized roles do not establish general cardiovascular prevention.
Studied preparation
The saved finding recognizes the included preparations as studied; this does not establish superiority over other forms.
Formulation logic100
No required partner is missing and no configured conflict was matched. The ingredients included in the amount check meet its threshold.
Partner coverage
The included ingredients have no unmet required partner in the supplied findings; this does not establish extra benefit from combining them.
Conflicts
No configured ingredient conflict was matched in the supplied findings.
Effective doses
All ingredients included in this check meet its amount threshold; excluded smaller amounts do not gain benefit from that finding.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Magnesium (TRAACS Magnesium Glycinate Chelate buffered) | 300 mg |
A serving supplies 300 mg of magnesium from buffered magnesium glycinate. That buffered source includes magnesium oxide, but its internal proportions are unknown.
How this ingredient is rated
Active Ingredient Quality & Bioavailability55
The sources include magnesium glycinate buffered. The buffered material includes magnesium oxide, and the proportions are unknown. A magnesium-specific branded material is identified in the saved facts.
Magnesium Form & Absorption Potential
The sources include magnesium glycinate buffered. The buffered material includes magnesium oxide, and the proportions are unknown.
Patented Materials & Chelation Quality
A magnesium-specific branded material is identified in the saved facts.
Dose, Safety & Label Transparency90
A serving provides 300 mg of magnesium. Calcium is recorded as 0 mg per serving; no positive amount of an evaluated cofactor is recorded.
Elemental Yield Transparency
The saved facts specify 300 mg of elemental magnesium per serving.
Therapeutic Dosage Alignment
A serving provides 300 mg of magnesium.
Synergistic Formulation Logic
Calcium is recorded as 0 mg per serving; no positive amount of an evaluated cofactor is recorded.
Value30
The whole-product serving costs about $0.56. The buffered source proportions are unknown.
Price Per Elemental Quality
The whole-product serving costs about $0.56. The buffered source proportions are unknown.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Association between Serum Magnesium and Fractures: A Systematic Review and Meta-Analysis of Observational Studies.
- Bioabsorbable Magnesium-Based Materials Potential and Safety in Bone Surgery: A Systematic Review.
- Vascularized bone grafting fixed by biodegradable magnesium screw for treating osteonecrosis of the femoral head.
- An update on magnesium and bone health.
- Sex-specific differences in the association of magnesium intake with femoral neck bone mineral density among older adults.
- Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies.
- Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies.
- Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.
- Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
- Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
- Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial.
- Total magnesium intake and risk of frailty in older women.
- Red blood cell magnesium and chronic fatigue syndrome.
- Exercise, magnesium and immune function.
- Perioperative systemic magnesium to minimize postoperative pain: a meta-analysis of randomized controlled trials.
- Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
- Association of magnesium sulfate use with mortality in critically ill patients with sepsis: a retrospective propensity score-matched cohort study.
- Hypomagnesemia and Mortality in Incident Hemodialysis Patients.
- The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial.
- Efficacy of oral magnesium therapy in the treatment of chronic constipation in spastic cerebral palsy children: a randomized controlled trial.